Brookfield Corporation
NYSE:BNAsset Management
-$0.32 today
- Market cap
- $87.93B
- Beta
- 1.84
- P/E (TTM)
- 83.3
- EPS (TTM)
- $0.53
- Dividend yield
- 0.59%
Volume 2.78M
Average 5.35M
BN Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Brookfield CorporationNYSE: BN
Accumulated OCI · Q3 FY2026 · quarter ended Sep 2026
Accumulated OCI remains negative
Q3 FY2026 Accumulated OCI was $0, compared with $9.74B a year earlier. Over 3 fiscal years it compounded at +28.5% a year.
Context
- Accumulated OCI amounted to 0.0% of total assets at the end of Q3 FY2026, down 1.9 pp from a year earlier.
- Accumulated OCI increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 16.11B USD
- Year-over-year change
- +82.2%
- 4-year CAGR
- +21.5%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.11B | +82.2% |
| FY2024 | 2024-12-31 | 8.84B | +8.3% |
| FY2023 | 2023-12-31 | 8.17B | +7.5% |
| FY2022 | 2022-12-31 | 7.59B | +2.6% |
| FY2021 | 2021-12-31 | 7.4B | — |
Accumulated OCI vs competitors
How BN compares with its peers on the latest reported figures
- BN's Sep 2026 Accumulated OCI of $0 is the 3rd highest of the 8 companies compared; the peer median is -$18.79M.
- Its year-over-year change of -100.0% is the lowest of 5, against a peer median of -21.4%.
- Accumulated OCI amounts to 0.0% of total assets for BN, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $13.12M | -59.2% | — | 0.0% | |
| Jun 2026 | $2.47M | +2.0% | — | 0.0% | |
| Sep 2026 | $0 | -100.0% | +28.5% | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | -$18.79M | — | — | 0.0% | |
| Sep 2026 | -$194.2M | — | — | 0.7% | |
| Jun 2026 | -$3.21B | +13.1% | — | 0.6% | |
| Sep 2026 | -$6.7B | -44.8% | — | 1.6% | |
| Peer median (excluding BN) | -$18.79M | -21.4% | — | 0.0% | |
Competitors are the stored peer set for BN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 12.69B | 14.4B | 11.22B | 15.05B | 16.24B |
| Short-term Investments | 6.96B | 7.57B | 5.67B | 5.13B | 0 |
| Net Receivables | 16.1B | 19.49B | 20.26B | 20.28B | 46.29B |
| Inventory | 8.56B | 9.11B | 7.06B | 5.42B | 8.85B |
| Other Current Assets | 11.96B | 2.83B | 2.49B | 10.29B | 0 |
| Total Current Assets | 56.27B | 53.39B | 46.7B | 56.18B | 71.38B |
| Property, Plant & Equipment (Net) | 115.49B | 124.27B | 147.62B | 153.02B | 251.61B |
| Goodwill | 20.23B | 28.66B | 34.91B | 35.73B | 43.36B |
| Intangible Assets | 30.61B | 38.41B | 38.99B | 36.07B | 38.5B |
| Long-term Investments | 55.68B | 66.43B | 81.78B | 89.07B | 109.91B |
| Tax Assets | 3.34B | 3.4B | 3.34B | 3.72B | 0 |
| Other Non-current Assets | 109.39B | 126.72B | 136.75B | 116.64B | 4.22B |
| Total Non-current Assets | 334.73B | 387.9B | 443.39B | 434.25B | 447.59B |
| Total Assets | 391B | 441.28B | 490.1B | 490.42B | 518.97B |
| Account Payables | 29.14B | 33.57B | 33.41B | 30.13B | 62.35B |
| Short-term Debt | 32.79B | 43.3B | 57.6B | 51.27B | 49.19B |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.15B | 876M | 118M | 4.72B | (49.19B) |
| Total Current Liabilities | 65.08B | 77.75B | 91.13B | 86.12B | 62.35B |
| Long-term Debt | 143.14B | 170.78B | 176.11B | 183.52B | 263.42B |
| Deferred Tax Liabilities | 20.33B | 23.19B | 24.99B | 25.27B | 26.96B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 27.72B | 27.68B | 29.62B | 30.14B | 49.15M |
| Total Non-current Liabilities | 191.19B | 221.65B | 230.72B | 238.92B | 290.43B |
| Total Liabilities | 256.26B | 299.39B | 321.85B | 325.04B | 352.78B |
| Common Stock | 10.54B | 10.9B | 10.88B | 10.81B | 10.82B |
| Retained Earnings | 17.71B | 18.01B | 18.01B | 17.07B | 16.63B |
| Accumulated OCI | 7.4B | 7.59B | 8.17B | 8.84B | 16.11B |
| Other Stockholders Equity | 6.24B | 2.96B | 4.51B | 5.05B | 0 |
| Minority Interest | 88.39B | 98.14B | 122.47B | 119.41B | 118.31B |
| Total Equity | 134.74B | 141.89B | 168.24B | 165.38B | 166.19B |
| Total Debt | 175.93B | 214.07B | 233.71B | 234.79B | 312.61B |
| Net Debt | 163.24B | 199.68B | 222.49B | 219.74B | 296.37B |
Brookfield Corporation
NYSE:BN
Intrinsic Alpha fair value
Locked
Current Price
$39.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.